Cathy Fong Fong Lam

Array ( [id] => 6401096 [patent_doc_number] => 20100305040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'PRODUCTION OF SOLUBLE RECOMBINANT PROTEIN BY PI VALUE CONTROL OF N-TERMINAL' [patent_app_type] => utility [patent_app_number] => 12/745187 [patent_app_country] => US [patent_app_date] => 2008-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22545 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305040.pdf [firstpage_image] =>[orig_patent_app_number] => 12745187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689738 [patent_doc_number] => 08389264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Recombinant microorganism that expresses a secY gene with deletion of sporulation-associated genes and method of producing thereof' [patent_app_type] => utility [patent_app_number] => 12/530135 [patent_app_country] => US [patent_app_date] => 2008-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14302 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 350 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12530135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807963 [patent_doc_number] => 20120058917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'Nucleic Acids and Libraries' [patent_app_type] => utility [patent_app_number] => 12/593770 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14493 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058917.pdf [firstpage_image] =>[orig_patent_app_number] => 12593770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6506387 [patent_doc_number] => 20100210527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'PRO- AND ANTI-ANGIOGENIC TREATMENTS' [patent_app_type] => utility [patent_app_number] => 12/530596 [patent_app_country] => US [patent_app_date] => 2008-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15604 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210527.pdf [firstpage_image] =>[orig_patent_app_number] => 12530596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573485 [patent_doc_number] => 20110269141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'TARGET PROTEIN AND TARGET GENE FOR DRUG DISCOVERY, AND SCREENING METHOD' [patent_app_type] => utility [patent_app_number] => 12/528190 [patent_app_country] => US [patent_app_date] => 2008-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 117726 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269141.pdf [firstpage_image] =>[orig_patent_app_number] => 12528190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431442 [patent_doc_number] => 20100152140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Method of Cancer Treatment with Naphthol Analogs' [patent_app_type] => utility [patent_app_number] => 12/529252 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16118 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152140.pdf [firstpage_image] =>[orig_patent_app_number] => 12529252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469611 [patent_doc_number] => 08298789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Orthogonal process for purification of recombinant human parathyroid hormone (rhPTH) (1-34)' [patent_app_type] => utility [patent_app_number] => 12/452919 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9891 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12452919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227372 [patent_doc_number] => 20120141577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'LINEAR EXPRESSION CASSETTE VACCINES' [patent_app_type] => utility [patent_app_number] => 11/949745 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16373 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11949745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6592410 [patent_doc_number] => 20100130564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'SMALL MOLECULE INHIBITORS OF BCL6' [patent_app_type] => utility [patent_app_number] => 12/312800 [patent_app_country] => US [patent_app_date] => 2007-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13813 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130564.pdf [firstpage_image] =>[orig_patent_app_number] => 12312800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220641 [patent_doc_number] => 20100055736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'VIRAL VECTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/516220 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21932 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055736.pdf [firstpage_image] =>[orig_patent_app_number] => 12516220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166502 [patent_doc_number] => 08592179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Artificial binding proteins based on a modified alpha helical region of ubiquitin' [patent_app_type] => utility [patent_app_number] => 12/514550 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16276 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12514550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6354855 [patent_doc_number] => 20100022404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor' [patent_app_type] => utility [patent_app_number] => 12/311535 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11934 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022404.pdf [firstpage_image] =>[orig_patent_app_number] => 12311535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6527905 [patent_doc_number] => 20100203637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Fluorescent cell markers' [patent_app_type] => utility [patent_app_number] => 12/310803 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3281 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203637.pdf [firstpage_image] =>[orig_patent_app_number] => 12310803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778776 [patent_doc_number] => 20080286774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Real-time individualized therapy evaluation' [patent_app_type] => utility [patent_app_number] => 11/821174 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3824 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286774.pdf [firstpage_image] =>[orig_patent_app_number] => 11821174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356041 [patent_doc_number] => 20100086932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD' [patent_app_type] => utility [patent_app_number] => 12/532139 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 13006 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086932.pdf [firstpage_image] =>[orig_patent_app_number] => 12532139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944876 [patent_doc_number] => 20110105496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Methods For The Treatment Of Myosin Heavy Chain-Mediated Conditions Using 4,7-Dihydrothieno[2,3-B]Pyridine Compounds' [patent_app_type] => utility [patent_app_number] => 12/158612 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 36734 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105496.pdf [firstpage_image] =>[orig_patent_app_number] => 12158612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527816 [patent_doc_number] => 20090197893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'Methods of Identifying and Treating Individuals Exhibiting Complex Karyotypes' [patent_app_type] => utility [patent_app_number] => 12/085733 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28431 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197893.pdf [firstpage_image] =>[orig_patent_app_number] => 12085733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285522 [patent_doc_number] => 20090099197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Methods of Identifying and Treating Individuals Exhibiting MDR-1 Overexpression With Protein Tyrosine Kinase Inhibitors and Combinations Thereof' [patent_app_type] => utility [patent_app_number] => 12/084861 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14323 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099197.pdf [firstpage_image] =>[orig_patent_app_number] => 12084861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337333 [patent_doc_number] => 20090053797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'GENETICALLY MODIFIED HOST CELLS AND USE OF SAME FOR PRODUCING ISOPRENOID COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/063831 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 24590 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053797.pdf [firstpage_image] =>[orig_patent_app_number] => 12063831 [rel_patent_id] =>[rel_patent_doc_number] =>)